News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hikma Pharmaceuticals Says FDA Lifts Warning On Eatontown Facility


4/2/2014 7:03:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Hikma Pharmaceuticals Plc said on Wednesday that the U.S. Food and Drug Administration had lifted the warning on its Eatontown facility in New Jersey where it makes oral products for the U.S. market. The Jordanian company, which makes and markets branded and non-branded generics and injectibles, said it was gradually reintroducing products to the U.S. market from the facility. The company had suspended manufacturing at the plant in 2012 after receiving an FDA warning letter.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at News Release
Read at in-Pharma Technologist


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES